You are here
News
May 3, 2013
MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
Award Honors Col. Michael's Excellence as an HIV Researcher and Leader in Global Health
Dr. Michael’s career has focused on developing an effective HIV vaccine to protect U.S. and Allied Armed Services and reduce the global impact of the disease. MHRP’s international research program has six clinical research sites in the U.S., Africa and Asia, where it conducts HIV cohort studies, HIV...
April 18, 2013
Duke and MHRP Win Award for Best Academic Research Team
A research team led by the Duke Vaccine Research Center and Walter Reed Army Institute of Research (WRAIR) won the “Best Academic Research Team” award at the 6th Vaccine Industry Excellence (ViE) Awards ceremony at the World Vaccine Congress held in Washington on April 17. LTC Robert O'Connell, Product Manager for HIV Vaccines for the U.S. Army Medical Research and Materiel Command, accepted...
April 8, 2013
Study finds low ART treatment costs and good retention at clinics in Kenya
Results can help inform resource allocation and budget decisions at the program level
The annual cost of providing antiretroviral therapy (ART) to HIV-infected patients in Kenya averaged $224, or less than $20 per month. A paper in the Journal of the International AIDS Society provides the first published estimate of the cost of ART treatment programs in Kenya—which is lower than what...
March 7, 2013
CROI 2013 Wrap-up
The annual Conference on Retroviruses and Opportunistic Infections (CROI) concluded on March 6 in Atlanta. This scientifically-focused meeting attracts more than 4,000 of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. There are two MHRP presentations to note. The first study, SEARCH/RV254, was conducted in Thailand and involved 68...
February 25, 2013
Large Multinational HIV Cohort Study Begins in Africa
The U.S. Military HIV Research Program (MHRP) has initiated a large, long-term cohort study at multiple African sites that will evaluate HIV prevention, care and treatment services it supports through local facilities, funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Named the African Cohort Study (AFRICOS), the study—the first of its kind in sub-Saharan Africa—is taking...
February 22, 2013
$6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
Following a recent investment from the National Institute of Allergy and Infectious Diseases (NIAID), a novel HIV vaccine candidate developed by MHRP scientists in collaboration with Advanced BioScience laboratories will be produced for potential use in clinical studies.
The move to further test the new protein boost vaccine candidate—a subtype C gp145 Env subunit vaccine—came about...
February 20, 2013
HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
Nearly half of participants receive HIV testing and counseling at the event
A team of officers from more than 50 Tanzania People's Defense Forces (TPDF) program sites convened in Mbeya, Tanzania in February to participate in a quarterly workshop and open house event that brings 2,000 people, military and civilian, together to learn about HIV/AIDS prevention and treatment services...
February 4, 2013
Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
Residents of Koome Island in Uganda have cause to smile after Makerere University Walter Reed Project (MUWRP), supported by the President’s Emergency Plan for AIDS Relief, handed over a newly refurbished health centre to the local district authorities on January 23, 2013. Koome comprises 16 smaller islands and is located in Lake Victoria.
Before renovations, the Koome Health Centre III—...
January 16, 2013
New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
A new study, led by a team at Duke Medicine and including researchers from the NIH Vaccine Research Center, MHRP, and the Thailand Ministry of Public Health, has provided additional insights into the workings of the RV144 vaccine. The findings, reported in the journal Immunity, are providing new options for vaccine designers to strengthen the vaccine.
“This study shows what types of...
December 18, 2012
In Memory of Sen. Daniel K. Inouye
Daniel K. Inouye, Hawaii’s senior Senator, World War II veteran, Medal of Honor recipient and long-time supporter of military medicine, passed away on December 17 at the Walter Reed National Military Medical Center.
Sen. Inouye led an accomplished life dedicated to public service. He grew up planning to become a doctor, but in 1942, as a teenager barely out of high school, he joined...